In the medical field, there is a category of pathological conditions known as very rare diseases because they affect a small number of individuals worldwide. These disorders typically have a genetic basis and require a specialized approach to both diagnosis and treatment. One such disease is Gaucher's disease, which poses a challenge not only to patients and their families but also to healthcare professionals. Raising awareness about this disease is crucial, hence it is important to familiarize oneself with its causes, symptoms, and available therapeutic options.
What is Gaucher's disease?
Gaucher's disease is a rare, inherited metabolic disorder that affects 1 in 40,000 to 60,000 people and belongs to the group of so-called storage diseases. It is caused by a mutation in the GBA gene, which codes for the enzyme glucocerebrosidase. This enzyme is responsible for the breakdown of glucocerebrosides, a fatty substance found in the cells of the body. As a result of the mutation in the GBA gene, the enzyme does not function correctly, leading to the accumulation of glucocerebrosides in various organs such as the liver, spleen, bone marrow, and in some cases, the nervous system.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.